» Articles » PMID: 21247287

Narrow-band Imaging Digital Flexible Ureteroscopy in Detection of Upper Urinary Tract Transitional-cell Carcinoma: Initial Experience

Overview
Journal J Endourol
Publisher Mary Ann Liebert
Date 2011 Jan 21
PMID 21247287
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To characterize the appearance of normal and malignant upper urinary tract lesion appearance under narrow-band imaging (NBI) using the new URF-V digital flexible ureteroscope (DFU), and to determine if NBI, when used in conjunction with white light (WL), could improve detection of malignancy.

Patients And Methods: NBI and WL were performed in 27 patients at our university teaching hospital, 14 with known cases of upper urinary tract transitional-cell carcinoma (UUT-TCC) as follow-up (group A), and 13 patients with first-suspicion of cancer (group B). Full renal collecting system examination was performed first under WL and then under NBI by a single urologist. Biopsies were taken from all detected lesions using the biopsy forceps and sent for examination by a pathologist who was blinded to the gross description of the lesion. Pathology interpretations were then compared with the corresponding WL and NBI images. Holmium laser vaporization was performed for all apparent lesions.

Results: Subjectively, NBI significantly improved the endoscopic visualization of the tumors, providing a detailed description of their limits and vascular architecture. Objectively, five additional tumors (14.2%) in four patients, as well the extended limits of three tumors (8.5%) in three patients were detected by NBI when findings by WL imaging were considered normal.

Conclusion: This is one of the first reports regarding NBI for UUT-TCC. From this study, we recommend this technology as a valuable diagnostic method, because it considerably improves tumor detection rate by 22.7% compared with WL.

Citing Articles

Diagnostic status and new explorations in upper urinary tract urothelial carcinoma: a literature review.

Shan Z, Deng X, Yang L, Zhang G Transl Androl Urol. 2024; 13(11):2570-2586.

PMID: 39698558 PMC: 11650341. DOI: 10.21037/tau-24-326.


The role of endoscopic management and adjuvant topical therapy for upper tract urothelial cancer.

Chien A, Chua K, Doppalapudi S, Ghodoussipour S Front Urol. 2024; 2.

PMID: 38855025 PMC: 11160966. DOI: 10.3389/fruro.2022.916259.


Diagnosing upper tract urothelial carcinoma: A review of the role of diagnostic ureteroscopy and novel developments over last two decades.

Gravestock P, Cullum D, Somani B, Veeratterapillay R Asian J Urol. 2024; 11(2):242-252.

PMID: 38680592 PMC: 11053284. DOI: 10.1016/j.ajur.2022.08.003.


Novel laser therapies and new technologies in the endoscopic management of upper tract urothelial carcinoma: a narrative review.

Myers A, Pak R Transl Androl Urol. 2023; 12(11):1723-1731.

PMID: 38106677 PMC: 10719773. DOI: 10.21037/tau-23-56.


Upper Tract Urothelial Carcinoma (UTUC) Diagnosis and Risk Stratification: A Comprehensive Review.

Bitaraf M, Ghafoori Yazdi M, Amini E Cancers (Basel). 2023; 15(20).

PMID: 37894354 PMC: 10605461. DOI: 10.3390/cancers15204987.